| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 95HB56U8P8 |
| InChI Key | DDYUBCCTNHWSQM-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C23H24N2O5 |
| Molecular Weight | 408.45 |
| AlogP | 3.23 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 98.93 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 30.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4A
|
- | 1100-1100 | - | - | - | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4B
|
- | 1100-1100 | - | - | - | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4C
|
- | 1100-1100 | - | - | - | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4D
|
- | 1100-1100 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL88153 |
| DrugBank | DB15640 |
| FDA SRS | 95HB56U8P8 |
| PubChem | 9844338 |
| SureChEMBL | SCHEMBL185853 |